Finanza

Notizie Discussioni Tecnici Previsione Stagionalità

Debito netto su Werewolf Therapeutics, Inc..

Dati annuali

2020

2021

2022

2023

2024

‪‪−160,00 M‬‬

‪‪−120,00 M‬‬

‪‪−80,00 M‬‬

‪‪−40,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

2024

‪‪−73,91 M‬‬

+‪‪8,51 M‬‬

+‪10,33‬%

2023

‪‪−82,42 M‬‬

+‪‪32,21 M‬‬

+‪28,10‬%

2022

‪‪−114,63 M‬‬

+‪‪27,34 M‬‬

+‪19,26‬%

2021

‪‪−141,97 M‬‬

‪‪−51,94 M‬‬

‪−57,69‬%

2020

‪‪−90,03 M‬‬

‪‪−82,57 M‬‬

‪‪−1,11 K‬‬%

Dati trimestrali

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−100,00 M‬‬

‪‪−75,00 M‬‬

‪‪−50,00 M‬‬

‪‪−25,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

Q4 '24

‪‪−73,91 M‬‬

+‪‪12,14 M‬‬

+‪14,11‬%

Q3 '24

‪‪−86,05 M‬‬

+‪‪12,58 M‬‬

+‪12,75‬%

Q2 '24

‪‪−98,63 M‬‬

‪‪−10,71 M‬‬

‪−12,18‬%

Q1 '24

‪‪−87,92 M‬‬

‪‪−5,50 M‬‬

‪−6,67‬%

Q4 '23

‪‪−82,42 M‬‬

‪‪−4,34 M‬‬

‪−5,56‬%

Q3 '23

‪‪−78,08 M‬‬

+‪‪6,55 M‬‬

+‪7,75‬%

Q2 '23

‪‪−84,64 M‬‬

+‪‪9,98 M‬‬

+‪10,55‬%

Q1 '23

‪‪−94,62 M‬‬

+‪‪20,02 M‬‬

+‪17,46‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21